%0 Journal Article
%T The value of molecular markers in classification and prediction of progression in non-muscle-invasive bladder cancer
%A Pan, Chin-Chen
%J Translational Andrology and Urology
%D 2018
%B 2018
%9 
%! The value of molecular markers in classification and prediction of progression in non-muscle-invasive bladder cancer
%K 
%X Urothelial carcinoma is the most common type of bladder cancer. The majority of urothelial carcinomas are low-grade, papillary, non-muscle invasive bladder cancer (NMIBC) treated by transurethral resection followed by intravesical instillation (1). The remaining carcinomas consist of high-grade, muscle-invasive tumors that are eligible for cystectomy. A significant proportion of NMIBC recur following TUR, and a minority will progress into high-grade tumors that are either muscle-invasive or metastatic tumor (2). For NMIBC treated by TUR, diligent follow-up plans are paramount to detect recurrence and progression.
%U https://tau.amegroups.org/article/view/20611
%V 7
%N 4
%P 736-739
%@ 2223-4691